Max Health™ announces approval of Milrinone injection in NZ

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 4/2/2016, Milrinone injection has been registered for use in New Zealand.  This product is manufactured in Europe and supplied to Max Health by Generic Health.

Distribution of Milrinone injection, and all other Max Health™ products, continues to be handled by OneLink.  Products can be ordered from OneLink on:

Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz

Buspirone 5mg and 10mg Tablets – Sole Supply Listing

Max Health™ is delighted to announce that it has been awarded Sole Supply Status for Buspirone 5mg and 10mg Tablets. Buspirone 5mg and 10mg Tablets are manufactured by Orion Corporation in Finland for Max Health™ in NZ and are now available for purchase.

Distribution of Buspirone 5mg and 10mg Tablets, and all other Max Health™ products, continues to be handled by Onelink. Buspirone 5mg and 10mg Tablets can be ordered from Onelink on:

Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz

Buspirone 5mg and 10mg Tablets details are as follows:

Name:  Buspirone 5mg
Strength: 5mg Tablets (pack of 100)
Onelink Code: PHAD89
Pharmacode: 2494132
Price: POA

Name:  Buspirone 10mg
Strength: 10mg Tablets (pack of 100)
Onelink Code: PHAD90
Pharmacode: 2494140
Price: POA

 

Buspirone 5 mg (3).jpg

Max Health™ announces NZ registration of Buspirone 5mg and 10mg tablets

Max Health™ is delighted to announce the advice received from Medsafe, that effective 10/12/2015, Buspirone 5mg and 10mg tablets have been registered for use in New Zealand. This product is manufactured in Finland and supplied to Max Health™ by Orion Corporation.

Distribution of Buspirone 5mg and 10mg tablets, and all other Max Health™ products, continues to be handled by OneLink.  Products can be ordered from OneLink on:

Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz

Max Health™ achieves NZ registration for Flumazenil injection

Max Health™ is pleased to announce the advice received from Medsafe, that effective 24/04/2015, Flumazenil injection has been registered for use in New Zealand.  This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.

Max Health™ announces NZ registration of Neostigmine injection

Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand.  This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.